6:27 PM
 | 
Jan 29, 2013
 |  BC Extra  |  Financial News

Keryx, NewLink propose follow-ons

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) and NewLink Genetics Corp. (NASDAQ:NLNK) proposed follow-ons late Tuesday. Keryx said it plans to raise $55 million in a follow-on underwritten by JPMorgan. On Monday, the company jumped 77% after reporting that Zerenex...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >